CompletedPhase 2NCT00423293
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
Studying Carcinoma of the anal canal
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radiation Therapy Oncology Group
- Principal Investigator
- Lisa A. Kachnic, MDBoston Medical Center
- Intervention
- fluorouracil(drug)
- Enrollment
- 63 enrolled
- Eligibility
- 18-120 years · All sexes
- Timeline
- 2006 – 2016
Study locations (30)
- Arizona Oncology - Tucson, Tucson, Arizona, United States
- Auburn Radiation Oncology, Auburn, California, United States
- Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
- Radiation Oncology Centers - Cameron Park, Cameron Park, California, United States
- Mercy Cancer Center at Mercy San Juan Medical Center, Carmichael, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
- Radiation Oncology Center - Roseville, Roseville, California, United States
- Radiological Associates of Sacramento Medical Group, Incorporated, Sacramento, California, United States
- Mercy General Hospital, Sacramento, California, United States
- Solano Radiation Oncology Center, Vacaville, California, United States
- University of Colorado Cancer Center at UC Health Sciences Center, Aurora, Colorado, United States
- Penrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States
- Veterans Affairs Medical Center - Denver, Denver, Colorado, United States
- St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · NRG Oncology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00423293 on ClinicalTrials.govOther trials for Carcinoma of the anal canal
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07029152Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisUniversitair Ziekenhuis Brussel
- ACTIVE NOT RECRUITINGPHASE3NCT06866574A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesXiamen University
- RECRUITINGPHASE2NCT06640283Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical OutcomesInstituto do Cancer do Estado de São Paulo
- RECRUITINGNANCT06792604Host Genome Methylation: a Screening Tool in Anal Cancer DetectionAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE3NCT06207981Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCAFederation Francophone de Cancerologie Digestive
- RECRUITINGPHASE2NCT05661188Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)Grupo Espanol Multidisciplinario del Cancer Digestivo
- RECRUITINGNCT06327568Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensEuropean Institute of Oncology
- RECRUITINGNCT05438836Re-optimization Based Online Adaptive Radiotherapy of Anal CancerHerlev Hospital